Suchergebnisse - "Pinato, David J"

PubPharm (285)

71

Impact of older age in patients receiving atezolizumab and bevacizumab for hepatocellular carcinoma

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2022

von Vithayathil, M. | D'Alessio, A. | Fulgenzi, C. | +32

CommentIn: Liver Int. 2022 Nov;42(11):2352-2353. - PMID 36162086

72

Association of prior local therapy and outcomes with programmed-death ligand-1 inhibitors in advanced urothelial cancer

enthalten in: BJU international | 2022

von Makrakis, D. | Talukder, R. | Diamantopoulos, L. | +44

73

COSMIC-312 : mounting immunotherapy enigmas for hepatocellular carcinoma

enthalten in: The Lancet. Oncology | 2022

von Cabibbo, G. | Celsa, C. | D'Alessio, A. | +2

CommentOn: Lancet Oncol. 2022 Aug;23(8):995-1008. - PMID 35798016

74

Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child-Pugh A and B cirrhosis : A real-world study

enthalten in: Hepatology (Baltimore, Md.) | 2022

von D'Alessio, A. | Fulgenzi, C. | Nishida, N. | +32

CommentIn: Hepatology. 2022 Oct;76(4):906-908. - PMID 35491442

75

enthalten in: Hepatology (Baltimore, Md.) | 2022

von D'Alessio, A. | Fulgenzi, C. | Pinato, D.

76

enthalten in: Hepatology (Baltimore, Md.) | 2022

von D'Alessio, A. | Fulgenzi, C. | Pinato, D.

77

Association Between Sites of Metastasis and Outcomes With Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma

enthalten in: Clinical genitourinary cancer | 2022

von Makrakis, D. | Talukder, R. | Lin, G. | +49

78

Comparative efficacy of novel combination strategies for unresectable hepatocellular carcinoma : A network metanalysis of phase III trials

enthalten in: European journal of cancer (Oxford, England : 1990) | 2022

von Fulgenzi, C. | D'Alessio, A. | Airoldi, C. | +5

79

Ketogenic Diet as a Chemopreventative and Therapeutic Strategy for Colon Cancer

enthalten in: Gastroenterology | 2022

von Pinato, D.

CommentOn: Nature. 2022 May;605(7908):160-165. - PMID 35477756

80

Efficacy outcomes and prognostic factors from real-world patients with advanced non-small-cell lung cancer treated with first-line chemoimmunotherapy : The Spinnaker retrospective study

enthalten in: International immunopharmacology | 2022

von Banna, G. | Cantale, O. | Muthuramalingam, S. | +14